In a melanoma model, depletion of NRF2 by shRNA significantly enhanced the infiltration of CD4 and CD8 T-cells to the tumor, reduced the proportion of MDSCs and overall improved anti-PD1 responses [72]. This evidence concerns the gene NFE2L2 and neoplasm.